Detail/result | Stenting alone (n = 83) | Stenting plus abciximab (n = 99) | P |
---|---|---|---|
Infarct artery stenting | 83 (100) | 98 (99) | NS |
Multiple stents | 18 (22) | 13 (11) | NS |
Abciximab administration | 7 (8) | 99 (100) | <0.005 |
Intraaortic balloon counterpulsation | 6 (7) | 3 (3) | NS |
Final TIMI grade 3 flow | 82 (99) | 98 (99) | NS |
Final minimal lumen diameter (mm) | 2.9 ± 0.5 | 2.8 ± 0.6 | NS |
Corrected TIMI frame count (25 frames/s) | 27.2 ± 10.7 | 25.6 ± 9.5 | NS |
Early ST-segment elevation resolution | 58 (73) | 88 (89) | <0.001 |
Peak creatine kinase | 2,570 ± 1,762 | 2,144 ± 1,989 | NS |
Time to peak creatine kinase (h) | 13 ± 4 | 10 ± 3 | <0.001 |
NS = not statistically significant.
Numbers in parentheses are percentages.